George Ng

George Ng, a partner at PENG Life Science Ventures, is a seasoned life sciences industry executive. He has founded and/or led multiple companies, including Scilex Pharmaceuticals, Inc., where he was Co-Founder and President leading the company through development, clinical trials, NDA submission, FDA approval, $140 million financing and commercial launch of the company’s first FDA-approved drug product. Mr. Ng has also held various other senior management positions within biotech and pharma, both private and publicly traded, including Sorrento Therapeutics, BioDelivery Sciences International, Inc., Spectrum Pharmaceuticals, Inc. and Alpharma, Inc. In these roles, Mr. Ng helped lead the development and commercialization efforts of multiple pharmaceuticals.

Previously, in private practice, Mr. Ng was a partner in two AMLAW 200 law firms, where he established the life sciences practice group for one firm. He is a current board member for multiple companies, including iActa Pharmaceuticals, Inc., Inflammatory Response Research, Inc. and Calidi Biotherapeutics, Inc. Mr. Ng served as President-Elect of the Pan Asian Lawyers of San Diego and is a frequent speaker and noted authority on legal, compliance and business issues in the life sciences. Among his multiple awards and commendations, Mr. Ng is a recipient of the Outstanding 50 Asian Americans in Business Award, M&A Advisor’s Top 40 Under 40 Award, and MDB Capital’s Best and Brightest Award and an Astrum Award nominee.

Mr. Ng earned his J.D. from the University of Notre Dame School of Law and his B.A.S. dual degree in Biochemistry & Economics from the UC, Davis.